Short CommunicationStability of compounded Trilostane (cas 13647-35-3) suspension in cod liver oil
-
Add time:09/06/2019 Source:sciencedirect.com
Trilostane (cas 13647-35-3) is a synthetic steroid analog used to treat canine hyperadrenocorticism. For small dogs, the dose found in commercially available dosage forms of trilostane is sometimes too high. Compounding trilostane in a liquid diluent provides an option for more precise dosing and adjustments, and can be easier to administer, versus a tablet or capsule. Trilostane suspends well in cod liver oil, which is generally palatable to dogs. The stability of a compounded trilostane suspension in cod liver oil stored at room temperature was investigated for 90 days. Compounded trilostane retained stability, defined as maintaining 90–105% labeled value, for 60 days when stored in amber glass bottles. However, drug potency fell >10% below the labeled value when stored in amber plastic bottles after 7 days.
We also recommend Trading Suppliers and Manufacturers of Trilostane (cas 13647-35-3). Pls Click Website Link as below: cas 13647-35-3 suppliers
Prev:Original ArticleIncidence and risk factors for hypoadrenocorticism in dogs treated with Trilostane (cas 13647-35-3)
Next:Trilostane (cas 13647-35-3)☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor Trilostane (cas 13647-35-3) in mice is related to changes in neuroactive steroid and monoamine levels09/24/2019
- Topical reviewMedical Management of Pituitary-Dependent Hyperadrenocorticism: Mitotane versus Trilostane (cas 13647-35-3)09/10/2019
- Short CommunicationExpression of 11β-hydroxysteroid dehydrogenase isoforms in canine adrenal glands treated with Trilostane (cas 13647-35-3)09/09/2019
- Possible Therapeutic Effect of Trilostane (cas 13647-35-3) in Rodent Models of Inflammation and Nociception09/08/2019
- Trilostane (cas 13647-35-3)☆09/07/2019
- Original ArticleIncidence and risk factors for hypoadrenocorticism in dogs treated with Trilostane (cas 13647-35-3)09/05/2019


